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and depression has been shown to be an independent risk factor for morbidity and mortality CHF. 6 Brain natriuretic peptide (BNP) is considered to represent a reliable marker for severity and treatment responsiveness of CHF. 7 N-Terminal Pro-ANP has been shown to play a role in modifying emotions, especially anxiety. 8, 9 These peptides and their receptors represent an important neuro-modulatory system within the central nervous system which directly exerts its influence on emotional behaviour, such as anxiety and arousal. 10 In CHF, patients who undergo a rehabilitation program may exhibit changes in anxiety, depression and quality of life, and in BNP as well. 11 The purpose of this study was to evaluate the changes in disease-specific quality of life, psychoemotional status and clinical markers of severity of CHF after a multidisciplinary out-patient rehabilitation program. We postulated that patients with higher concentrations of BNP score higher on anxiety and depression and lower on quality of life measures compared to those who score lower on anxiety and depression and higher on disease specific quality of life. The analysis is part of a comprehensive evaluation of the rehabilitation program which was developed and implemented in the University Hospital setting for the first time.
Patients and Methods
In this case series twenty five patients (20 male/5 female) with clinically stable CHF underwent a 12-week comprehensive rehabilitation program. Patient characteristics are presented in Table 1 . Etiology of CHF was coronary artery disease (n=8/1), dilated/ idiopathic cardiomyopathy (n=9/3), and other factors such as RV dysplasia (1/0), and cytostatica induced cardiomyopathy (2/1). Inclusion criteria were stable heart failure for at least 3 months and optimized medication regimen unchanged for more than 1 month. Before and in the course of intervention, 13 patients received a triple therapy (including betablockers, diuretics, and ACE-inhibitors), 8 had a twodrug regimen (including beta-blockers or ACEinhibitors, and diuretics), whereas 4 patients were exclusively treated with A-II blockers. Exclusion criteria were resting-or exercise-induced angina pectoris, electrocardiographic evidence for myocardial ischemia in resting conditions, significant arrhythmia, orthopedic or neurological disorders, severe chronic obstructive pulmonary disease, and peripheral arterial occlusive disease. The study protocol was approved by the local Ethics Committee of the University of Bern. Before inclusion, all patients had given their written informed consent to the study.
Education Program
Once a week, patients and their partners attended 1.5-hour counseling session, which spouses or other family members could attend upon request. Counseling was offered by a team of multidisciplinary health professionals including dieticians, psychologists, physicians, and exercise therapists. It focused on the role of sodium restriction and fluid intake, pharmacological therapy and its side effects, warning symptoms of progressive heart failure and guidelines on how to act, adherence to dietary and medical therapy, physical activity in daily living, and sexuality. Additionally, psychological support in coping with heart failurerelated problems was offered to patients and partners. . Peak oxygen uptake (VO2; ml/kg/min) was measured breath by breath with an Oxycon Sigma system (E. Jaeger AG, Würzburg, Germany); for detailed methods see 12 ).
Determination of Brain Natriuretic Peptide
Five milliliters venous blood was taken to determine brain natriuretic peptide (BNP; pg/ml) by fluorescence immunoassay (Triage BNP-Test, Biosite Diagnostic).
Measurement of Quality of Life
Physical, psychological, and socio-economic impairment was assessed by means of the 21-item Minnesota Living with Heart Failure Questionnaire (MLHFQ) -a self-administered and disease-specific instrument. 15 Using a Likert-scale, answers were given by choosing a score between 0 (no impairment) and 5 (very much impaired), resulting in a total score variation from 0 (no impairment) to 105 (severe impairment). The higher the score, the more severely impaired a patients feels.
Assessment of Psycho-Emotional Status
To measure anxiety and depression, the 14-item Hospital Anxiety and Depression Scale (HADS) 16, 17 was administered. This questionnaire is a screening test for clinically important anxiety (7 items) and depression (7 items) with high re-test reliability. 18 Each item has 4 answer options. After calculation of the sum scores of each of the 2 scales, a sum score of > 10 confirms the presence of a disorder, whereas as score < 8 indicates that there is none.
To assess anger components the 44 item StateTrait Anger Expression Inventory (STAXI) 19 was used to assess situational anger (state anger, 10 items), trait anger (10 items), anger-in (8 items), anger-out (8 items), and anger control (8 items). All items are rated by means of a 4-step Likert Scale, and component values are calculated by adding the respective Likert values.
Statistics
Statistical analysis was performed using SPSS 13.0 (Statistical Package for Social Sciences, Windows Version, SPSS Inc. Los Angeles, USA). Descriptive statistics included arithmetic mean and standard deviation for numeric, continuous, and categorical variables. For dependent samples, the Student's t-test was applied to calculate changes in outcome parameters between baseline and week 12 of intervention. When ordinal variables had to be distinct, the Kendall or the Spearman Test was used. To determine evidence of strength of changes in quality of life scores, the effect sizes of normalized values were calculated by relating mean change (baseline versus week 12) divided by standard deviation of measures obtained at week 12. Otherwise, Z-transformed values were used to correct for possible skewness of the distribution of distinct variables. In order to assess differences of effects on quality of life parameters, a median half-split for baseline ejection fraction ( LVEF < 30 versus 30%) was calculated. By using unpaired t-tests the subgroups were compared for changes in disease specific quality of life variables. Correlations were determined by Pearson's correlation coefficient (r). Two-sided Pvalues <0.05.
Results

Disease-Specific Quality of Life
The initial sum score of the MLHFQ indicated moderate impairment in quality of life (Table 2) After rehabilitation significant improvements in the physical component score and total score were discernible.
Anxiety, Depression and Anger
Initially, mean sum values of both Hospital Anxiety Depression Scale (HADS) for anxiety and depression were in the normal range of values (i.e. < 8 for both). Compared with the initial values, mean values of depression and anxiety scores did improve significantly (Table 3) .
At baseline, mean values of all State and Trait Anger Expression Inventory (STAXI) scores on anger were also within the range of age-and genderadjusted normal values. However, at the end of rehabilitation all mean scores had significantly improved (Table 3) .
Focusing on individual patients' scores at baseline, 2 of the 25 patients' (7%) qualified for a mildly depressed mood, and 4 patients (14%) indicated an abnormally elevated anxiety sum score (cut-off scores for both 10). At the end of the study, although all individual scores above the cut-off level had improved (i.e. were lower), one of the depressed and two of the anxious patients still scored abnormally high (i.e. 10). 
Correlations between Anxiety, Depression, Anger and Quality of Life
At baseline anxiety, depression, and anger control were significantly associated with emotional component score, mental health, and mental sum score of disease specific quality of life (Table 4a) .
After rehabilitation, changes in anxiety and depression from HADS were significantly correlated with the physical and emotional component score and of the scores of disease specific quality of life measures (Table 4b) 
Correlations between Anger, Anxiety, Depression, and BNP
The LVEF of the total group (range: 15-43%), was used to split patients up into severely and moderately impaired left ventricular function, respectively. A median of 30% was used to determine possible differences in psycho-emotional scores (depression, anger, anxiety (Table 5 ).
In patients with LVEF 30%, percent changes in BNP observed during the course of rehabilitation correlated significantly with those in anxiety and anger. In addition, percent change in emotional distress was associated with percent changes in both, disease specific physical component score and emotional score of the MLHFQ (Table 6) .
Discussion
This paper represents explorative findings based on evaluation of a pilot rehabilitation program. Multiple studies 6, 20, 21 have yielded evidence for an interdependence between clinical and functional status and quality of life CHF. A limited number of studies have focused on anxiety and depression in CHF (for overview see 2 ). It remains unclear whether a multidisciplinary CHF rehabilitation program involving pharmacological treatment, exercise training, education, counseling and emotional support could modify anxiety and depression along with improving clinical status and quality of life. Since a multidisciplinary rehabilitation program should be near daily practice, our pilot study evaluated its gross effect but not the relative impact of a single intervention component.
Clinical Status and Quality of Life
Twelve weeks of rehabilitation resulted in an improvement of clinical parameters (NYHA class, LVEF) and peak VO2 (Table 1) . Besides, disease specific physical functioning and quality of life sum score improved (Table 2 ).
In the patients who exhibit NYHA class II, the initial mean quality of life sum score of 31.9 indicated a moderate impairment. Similar sum scores were reported for an American and a German heart failure reference population in NYHA class II and III patients. 22, 23 In 3 months of rehabilitation, improvements by 36% in sum score and by 41% in physical component score on average corresponded to improvements of 30%, 37% and 22% on average for sum score, physical and emotional component scores, which were reported after 2 and 14 months of exercise training, respectively. 24 Improved clinical status and exercise capacity might have enabled patients to cope better with their everyday lives, thereby becoming more self-reliant and emotionally more stable. 25 This could be the reason for an improvement in the disease-specific quality of life.
Anxiety and Depression
Although at baseline the mean scores of patients did not indicate anxiety or depression (i.e. 8), mean values of both scales did improve throughout the rehabilitation period as indicated by a decrease in values ( Table 3 ). The two and four patients, respectively, who exhibited pathological depression and anxiety sum scores demonstrated lower values after the 12 week rehabilitation program, suggesting a positive effect on emotional functioning. Carels et al. found that the impact of depression on quality of life in CHF patients was more pronounced than the impact of severity of heart failure as defined by LVEF. 26 Not only quality of life but also depression has been demonstrated to be directly associated to survival in CHF patients 2, 6 . Moreover, in the Montreal Heart Attack Readjustment Trial (M-Hart) results indicated that highly anxious men might significantly increase their chances of long-term survival by modifying their coping styles. 27 These experiences imply the importance of both recognizing and treating anxiety and depression in patients with CHF so as to improve their quality of life.
Neurohumoral Markers of Changes of Anxiety and Depression
We tested the association of BNP to psycho-emotional and quality of life measures. In patients with LVEF 30%, percent change in BNP in the course of rehabilitation correlated significantly with percent change in anxiety and anger, which was not the case in the group with LVEF <30% (Table 6 ). This might be an indication that BNP could attenuate central arousal effects by lowering sympathetic outflow. 10 BNP has been reported to be attenuated. 28 These facts may partly explain why correlations of BNP concentrations to psycho-emotional factors were not found in patients who exhibited ejection fraction below 30%.
Study Limitations
The paper presents explorative findings based on an evaluation of a pilot multidisciplinary out-patient rehabilitation program. A control group was not included in the design due to the fact that a pilot program is under investigation. However, according to a consensus of the Association Francophone pour la Prévention et la Réadapatation Cardiovasculaire, lack of a control group is partly justified granted the unethical aspects of restraining CHF patients totally from rehabilitation. The small number of patients may not be representative for stable CHF patients who participate in such programs. When assessing parameters of quality of life, depression and anxiety, a reporting bias could affect the results. In our study, psychoemotional factors such as depression, anger, and anxiety have been measured by means of questionnaires. Since self-reports are often less sensitive in diagnosing psycho-emotional disorders, the instruments used may have underestimated the effective prevalence of these emotional disturbances. 29 BNP concentrations are known to be reduced after beta blocker treatment 30 , whereas plasma concentrations are reported to increase after treatment with angiotensin-converting inhibitors. 31 Thus, an uncertain amount of variance of BNP has to be taken into account in a thorough interpretation of our data.
Need for Future Research
Randomized controlled trials are needed to verify the association of improvement in quality of life and improvement of anxiety and depression in relation to clinical severity of disease in CHF patients undergoing multidisciplinary rehabilitation. Focusing on the field of psychological and neurobiological adaptation, the mechanism underlying the improvement in anxiety and depression should be clarified. The question whether the natriuretic peptides, namely BNP, are reliable clinical markers for anxiety and depression in CHF -as is true for severity and treatment responsiveness -should be examined.
Clinical Implications
This pilot study demonstrated that rehabilitationinduced improvements of disease-specific quality of life are closely associated with improvement in psycho-emotional status and clinical severity of CHF.
